Otto Krayer
Otto Krayer
1Department of Pharmacology, Harvard Medical School of Harvard University at the Massachusetts General Hospital, Boston, Mass.
2Medical Laboratories of the Collis P. Huntington Memorial Hospital of Harvard University at the Massachusetts General Hospital, Boston, Mass.
1,2,
Joseph C Aub
Joseph C Aub
1Department of Pharmacology, Harvard Medical School of Harvard University at the Massachusetts General Hospital, Boston, Mass.
2Medical Laboratories of the Collis P. Huntington Memorial Hospital of Harvard University at the Massachusetts General Hospital, Boston, Mass.
1,2,
Ira T Nathanson
Ira T Nathanson
1Department of Pharmacology, Harvard Medical School of Harvard University at the Massachusetts General Hospital, Boston, Mass.
2Medical Laboratories of the Collis P. Huntington Memorial Hospital of Harvard University at the Massachusetts General Hospital, Boston, Mass.
1,2,
Paul C Zamecnik
Paul C Zamecnik
1Department of Pharmacology, Harvard Medical School of Harvard University at the Massachusetts General Hospital, Boston, Mass.
2Medical Laboratories of the Collis P. Huntington Memorial Hospital of Harvard University at the Massachusetts General Hospital, Boston, Mass.
1,2
1Department of Pharmacology, Harvard Medical School of Harvard University at the Massachusetts General Hospital, Boston, Mass.
2Medical Laboratories of the Collis P. Huntington Memorial Hospital of Harvard University at the Massachusetts General Hospital, Boston, Mass.
1 This is publication No. 632 of the Cancer Commission of Harvard University, and No. X in the series entitled “The Toxic Factors in Experimental Traumatic Shock.”
2 The work described in this paper was done under a contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and the Massachusetts General Hospital.
3 Grateful acknowledgment is due the Josiah Macy, Jr. Foundation for a grant for the histopathological studies.